Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1977-12-29
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-1526
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
274-8
|
pubmed:dateRevised |
2008-2-13
|
pubmed:meshHeading |
pubmed-meshheading:919738-Adenosine Triphosphate,
pubmed-meshheading:919738-Blood Preservation,
pubmed-meshheading:919738-Erythrocytes,
pubmed-meshheading:919738-Filtration,
pubmed-meshheading:919738-Humans,
pubmed-meshheading:919738-Male,
pubmed-meshheading:919738-Pentoxifylline,
pubmed-meshheading:919738-Theobromine
|
pubmed:year |
1977
|
pubmed:articleTitle |
Microrheological effects of the vasoactive compound 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifylline, BL 191).
|
pubmed:publicationType |
Journal Article
|